Alopecia Treatment Market to Reach $14.16 Billion, Globally, by 2030 at 5.6% CAGR: Coherent Market Insights
07 déc. 2023 03h14 HE
|
CMI
Burlingame, Dec. 07, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, The global alopecia treatment market was valued at US$ 9.65 Billion in 2023 and is forecast to reach a value of...
Eli Lilly's Olumiant and Pfizer's Litfulo Strengthen Alopecia Areata Arsenal, Yet Resounding Opportunity for JAK Expansion and New Assets in Development Remain
15 nov. 2023 11h22 HE
|
Spherix Global Insights
Exton, Pennsylvania, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Spherix Global Insights has been monitoring the alopecia areata (AA) market for the past four years and has found that the entry of JAK...
Triple Hair Group signe une entente de licence avec Mother's Pharmaceutical pour le marché sud-coréen
17 oct. 2023 07h30 HE
|
Triple Hair Inc.
L'entente de licence accorde à Mother's Pharmaceutical les droits exclusifs de vente du médicament sur ordonnance Thérapie-07 de Triple Hair en Corée du Sud.L'entente est évaluée à 5,75 M$ US en...
Triple Hair Group Signs Licensing Agreement for South Korean Market with Mother’s Pharmaceutical
17 oct. 2023 07h30 HE
|
Triple Hair Inc.
Licensing agreement grants Mother’s Pharmaceutical exclusive rights to sell Triple Hair’s Therapy-07 prescription drug in South Korea.Agreement valued at US$5.75 million in upfront and milestone...
Global Alopecia Market Size To Grow USD 13.7 Billion By 2030 | CAGR 7.7%
09 mars 2023 12h30 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , March 09, 2023 (GLOBE NEWSWIRE) -- The Global Alopecia Market Size to grow from USD 7.1 billion in 2021 to USD 13.7 billion by 2030, at a Compound Annual Growth Rate (CAGR)...
Insights on the Alopecia Treatment Global Market to 2027 - by Condition Type, Medication Type and Geography
06 janv. 2023 08h38 HE
|
Research and Markets
Dublin, Jan. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Alopecia Treatment Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.The global alopecia...
Triple Hair Group annonce le lancement d’une plateforme de télémédecine pour le diagnostic et le traitement de l’alopécie androgénique
15 nov. 2022 07h30 HE
|
Triple Hair Inc.
La plateforme Hair Loss Rx Consult (hairlossrxconsult.ca) fournira un diagnostic sur l'état de la perte de cheveux et recommandera le meilleur traitement disponible.La plateforme permettra également...
Triple Hair Group announces the launch of a telehealth platform for the diagnosis and treatment of androgenic alopecia
15 nov. 2022 07h30 HE
|
Triple Hair Inc.
Hair Loss Rx Consult platform (hairlossrxconsult.ca) will provide hair loss condition diagnosis and recommend best treatment available.Platform will also provide access to prescriptions for topical...
Triple Hair Group annonce un accord stratégique avec Pharmacy Solutions, un chef de file américain dans la préparation de médicaments
21 juin 2022 07h30 HE
|
Triple Hair Inc.
L'accord comprend une entente de licence pour les produits brevetés de Triple Hair aux États-Unis.Pharmacy Solutions est spécialisée dans les médicaments en vente libre et sur ordonnance contre la...
Triple Hair Group announces strategic arrangement with leading US compounding company Pharmacy Solutions
21 juin 2022 07h30 HE
|
Triple Hair Inc.
The arrangement includes a licensing agreement for Triple Hair’s patented products in the USPharmacy Solutions specializes in over-the-counter and prescription hair loss medications, offering...